Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024
Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in surgical solutions for spinal disorders, has announced its upcoming second quarter 2024 financial results release and earnings conference call. The company will disclose its financial results for the quarter ended June 30, 2024, after market close on Thursday, August 8, 2024.
A conference call to discuss the results is scheduled for Friday, August 9, 2024, at 9:00 AM ET. The call will be hosted by Sean Browne, President and CEO, and Scott Neils, CFO. Investors can join via phone or webcast, with replay available on the company's website post-call.
Xtant Medical Holdings (NYSE American: XTNT), un'azienda globale di tecnologia medica specializzata in soluzioni chirurgiche per disturbi spinali, ha annunciato la prossima pubblicazione dei risultati finanziari del secondo trimestre 2024 e la relativa conference call sugli utili. L'azienda renderà noti i risultati finanziari per il trimestre concluso il 30 giugno 2024, dopo la chiusura del mercato di giovedì 8 agosto 2024.
Una conference call per discutere i risultati è programmata per venerdì 9 agosto 2024, alle 9:00 AM ET. La chiamata sarà condotta da Sean Browne, Presidente e CEO, e Scott Neils, CFO. Gli investitori possono partecipare tramite telefono o webcast, con la possibilità di riascoltare la registrazione sul sito web dell'azienda dopo la chiamata.
Xtant Medical Holdings (NYSE American: XTNT), una empresa global de tecnología médica especializada en soluciones quirúrgicas para trastornos de la columna, ha anunciado la próxima publicación de sus resultados financieros del segundo trimestre de 2024 y la conferencia telefónica sobre ganancias. La compañía dará a conocer sus resultados financieros para el trimestre que terminó el 30 de junio de 2024, después del cierre del mercado el jueves 8 de agosto de 2024.
Una conferencia telefónica para discutir los resultados está programada para viernes 9 de agosto de 2024, a las 9:00 AM ET. La llamada será presentada por Sean Browne, Presidente y CEO, y Scott Neils, CFO. Los inversores pueden unirse a través de teléfono o webcast, con una repetición disponible en el sitio web de la empresa después de la llamada.
Xtant Medical Holdings (NYSE American: XTNT)는 척추 질환을 위한 외과적 솔루션에 특화된 글로벌 의료 기술 회사로, 2024년 2분기 재무 결과 발표 및 수익 컨퍼런스 콜을 곧 실시할 예정입니다. 이 회사는 2024년 6월 30일로 종료된 분기의 재무 결과를 2024년 8월 8일 목요일 시장 마감 후에 발표할 예정입니다.
결과를 논의하기 위한 컨퍼런스 콜은 2024년 8월 9일 금요일 오전 9시(ET)로 예정되어 있습니다. 이 통화는 Sean Browne, 사장 겸 CEO, 및 Scott Neils, CFO가 주최합니다. 투자자들은 전화 또는 웹캐스트를 통해 참여할 수 있으며, 통화 후 회사 웹사이트에서 다시 들을 수 있는 옵션이 제공됩니다.
Xtant Medical Holdings (NYSE American: XTNT), une entreprise mondiale de technologie médicale spécialisée dans les solutions chirurgicales pour les troubles de la colonne vertébrale, a annoncé la prochaine publication de ses résultats financiers pour le deuxième trimestre de 2024 et la conférence téléphonique sur les bénéfices qui l'accompagne. La société divulguera ses résultats financiers pour le trimestre clos le 30 juin 2024, après la fermeture du marché, le jeudi 8 août 2024.
Une conférence téléphonique pour discuter des résultats est prévue pour le vendredi 9 août 2024 à 9h00 ET. L'appel sera animé par Sean Browne, Président et CEO, et Scott Neils, CFO. Les investisseurs peuvent participer par téléphone ou par webcast, avec une rediffusion disponible sur le site web de l'entreprise après l'appel.
Xtant Medical Holdings (NYSE American: XTNT), ein globales Medizintechnikunternehmen, das auf chirurgische Lösungen für Wirbelsäulenerkrankungen spezialisiert ist, hat die bevorstehende Veröffentlichung seiner finanziellen Ergebnisse für das zweite Quartal 2024 sowie die dazugehörige Gewinnkonferenz bekannt gegeben. Das Unternehmen wird seine finanziellen Ergebnisse für das am 30. Juni 2024 endende Quartal nach Börsenschluss am Donnerstag, den 8. August 2024 bekannt geben.
Eine Konferenztelefonat zur Diskussion der Ergebnisse ist für Freitag, den 9. August 2024, um 9:00 Uhr ET geplant. Das Gespräch wird von Sean Browne, Präsident und CEO, und Scott Neils, CFO, moderiert. Investoren können telefonisch oder über Webcast teilnehmen, wobei eine Aufzeichnung nach der Konferenz auf der Unternehmenswebsite verfügbar sein wird.
- None.
- None.
BELGRADE, MT / ACCESSWIRE / August 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 2024, after the close of the financial markets on Thursday, August 8, 2024.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Friday, August 9, 2024, at 9:00 AM ET to review results.
Conference Details:
Conference Date: Friday, August 9, 2024
Conference Time: 9:00 AM ET
Conference dial-in: 888-999-3182
International dial-in: 848-280-6330
Passcode: Xtant Medical Holdings
Conference Call Name: Xtant Medical Q2 2024 Financial Results
Webcast Link: https://www.webcaster4.com/Webcast/Page/3039/50961
Following the live call, a replay will be available on the Company's website, https://xtantmedical.com/, under "Investor Info."
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
Brett Maas • Managing Partner, Hayden IR
brett@haydenir.com • (646) 536-7331
SOURCE: Xtant Medical Holdings, Inc.
View the original press release on accesswire.com
FAQ
When will Xtant Medical (XTNT) release its Q2 2024 financial results?
What time is Xtant Medical's (XTNT) Q2 2024 earnings conference call?
Who will host Xtant Medical's (XTNT) Q2 2024 earnings call?
How can investors access Xtant Medical's (XTNT) Q2 2024 earnings call?
